Status:
COMPLETED
In Vivo Measurement of the Accuracy of the "Neurolocate" Module of the Neurosurgical Robot "Neuromate" in Its Application to Deep Brain Stimulation
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Parkinson Disease
Dystonia
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study is to evaluate the accuracy of the Neurolocate recording system of the neurosurgical robot Neuromate, marketed by Renishaw, in order to optimize surgical procedures, costs an...
Detailed Description
Robotic neurosurgery has been developed for nearly 25 years and offers neurosurgeons many advantages, including increased precision. Accuracy is a key point for stereotactic neurosurgical procedures,...
Eligibility Criteria
Inclusion
- Patients aged 18 to 70 years old requiring a stereotactic robot-guided deep brain stimulation procedure
- Signature of the Informed Consent Form
- Affiliation to the French social security system
Exclusion
- Contraindication to MRI
- Hypersensitivity to gadoteric acid, meglumine or any product containing gadolinium.
- Anterior and posterior commissure anatomy modifying brain anatomy
- Patient unable to complete the Comfort Questionnaire due to cognitive or speech impairment
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
January 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 7 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04712552
Start Date
January 26 2021
End Date
January 7 2023
Last Update
June 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of neurosurgery
Nice, France, 06000